Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.26 USD | +0.27% | -3.72% | -10.37% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.37% | 3.38B | |
-1.54% | 91.26B | |
-2.37% | 38.17B | |
+71.42% | 26.74B | |
-12.08% | 15.93B | |
-3.95% | 13.37B | |
-10.83% | 11.77B | |
+180.20% | 10.92B | |
-48.60% | 10.27B | |
+1.42% | 8.69B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics Q1 Loss Widens, Revenue Declines -- Shares Advance Pre-Bell